GUIDE DBS is the World's First Deep Brain Stimulation Visual Simulation System NATICK, Mass., Boston Scientific Corporation has received CE Mark approval for use of the GUIDE™ DBS System, the world's ...

Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...

Shabbar Danish, chief, Neurosurgery, Rutgers Cancer Institute, and director of Stereotactic and Functional Neurosurgery at RWJUH, successfully implanted the device in the first patient Oct. 25 at ...

Newronika has completed a €13.6m ($14.1m) Series B funding to advance the development of AlphaDBS, an adaptive deep brain stimulation (DBS) system for addressing the symptoms of Parkinson’s disease.

The US Food and Drug Administration (FDA) has approved a new software upgrade for Abbott's Infinity deep-brain stimulation (DBS) system used in patients with Parkinson's disease and essential tremor, ...

NEW ORLEANS — A new multiple-source system for deep-brain stimulation (DBS) in patients with Parkinson's disease proved effective in the randomized, double-blind INTREPID trial, meeting its primary ...

Medtronic plc MDT recently announced receipt of the FDA’s approval for its Percept PC Deep Brain Stimulation (“DBS”) system. The inclusion of the BrainSense technology with the Percept PC DBS system ...

Boston Scientific Corporation BSX recently announced the receipt of the FDA’s approval for its fourth-generation Vercise Genus Deep Brain Stimulation (“DBS”) System. Notably, the DBS portfolio is ...